HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006

AIDS Research and Human Retroviruses

Volumn 23, Issue 9, 2007, Pages 1155-1160

  Toni, Thomas D'Aquin ^a,b   Masquelier, Bernard ^c   Minga, Albert ^a   Anglaret, Xavier ^a,d   Danel, Christine ^a   Coulibaly, Ali ^a   Chenal, Henri ^b   Dabis, François ^d   Salamon, Roger ^d   Fleury, Hervé J ^c,e  

^a Programme PAC CI/Primo CI ANRS 1220   (Côte d’Ivoire)

^b Centre Integrée de Recherches Bioclinique d'Abidjan   (Côte d’Ivoire)

^c University Victor Segalen   (France)

^d INSERM   (France)

^e HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; COTE D'IVOIRE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS ISOLATION; VIRUS MUTATION; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; COTE D'IVOIRE; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, DNA;

EID: 35348857692     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0072     Document Type: Article

References (9)

1. Hirsch MS, Brun-Vezinet F, Clotet B, et al.: Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37:113-128.
2. Minga A, Abo Y, Dohoun L, et al.: Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire. Bull World Health Org 2007;85:116-123.
3. Salamon R, Marimoutou C, Ekra D, et al.: Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr 2002;29:149-157.
4. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
5. Toni TD, Recordon-Pinson P, Minga A, et al.: Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. AIDS Res Hum Retroviruses 2003;19:713-717.
6. Toni T, Adje-Toure C, Vidal N, et al.: Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa. AIDS Res Hum Retroviruses 2005;21:667-672.
7. Dabis F, Bequet L, Ekouevi DK, et al.: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005;19:309-318.
8. Diop YB, Ba-Gomis D, Dahourou,G. Hatzakis G, Nguyen V, Sy KC, and Chenal H: Prospective trial of CBV + IDV in West Africa. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, 2001 [abstract 492].
9. Adje C, Cheingsong R, Roels TH, et al.: High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr 2001;26:501-506.